RANDALL MARK EDWARD purchased 22.4% of their position (70K shares) of TC BIOPHARM (HOLDINGS) PLC on the open market
Open‑market purchase worth $350.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/11/2023ACC: 0001920179-23-000003
10% Owner
Since Nov 2022
+210K
Net shares
Net buyer
$350.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
210K acquired
Non-Derivative Transactions1
Ordinary Shares [ADS]
Indirect
Shares
+70K
Price / share
$5.00
Trade value
$350K
% of position
22.4%
11/30/2022
312.96K→382.96K
Total
Net shares
+70K
Net value
$350K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares [ADS] Indirect | 11/30/2022 | P · Purchase | +70K | $5.00 | $350K | 22.4% | 312.96K | 382.96K |
| Total | +70K | $350K | ||||||
Derivative Transactions2
Series A Warrants
Indirect
Converts to
Ordinary Shares
70K shares
Shares
+70K
Strike price
5
Held after
70K
Exercisable
—
11/30/2022
Series B Warrants
Indirect
Converts to
Ordinary Shares
70K shares
Shares
+70K
Strike price
5
Held after
70K
Exercisable
—
11/30/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Warrants Indirect | Ordinary Shares70K shares | 11/30/2022 | P · Purchase | +70K | 5 | — | 70K |
| Series B Warrants Indirect | Ordinary Shares70K shares | 11/30/2022 | P · Purchase | +70K | 5 | — | 70K |
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares [ADS]
DirectShares owned9.95K
Total
9.95K direct9.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares [ADS] | 9.95K | Direct |
| Total | 9.95K | 9.95K direct |
Derivative Holdings (Post-Transaction)1
Warrants
IndirectUnderlying security
Ordinary Shares
Underlying shares
106.13K
Shares owned
106.13K
Exercise price
4.25
Expiration
—
Exercise window
—
Total
Underlying
106.13K
Owned
106.13K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Indirect | Ordinary Shares | 4.25 | — | — | 106.13K | 106.13K |
| Total | 106.13K | 106.13K | ||||